The 100 Most Cited Androgenetic Alopecia Articles: An Analysis of Altmetrics Data from 2015 to 2022

    May 2024 in “ Skin appendage disorders ”
    Advaitaa Ravipati, Tejus Pradeep, Antonella Tosti
    Image of study
    TLDR Healthcare professionals are selective in reading, while the public struggles to find reliable dermatology sources.
    The analysis of the 100 most cited androgenetic alopecia articles from 2015 to 2022 reveals that articles with higher Altmetric Attention Scores are cited more frequently. Open-access articles are less likely to be read by healthcare professionals, while funded studies and those published in high-impact journals have higher readership odds. Interest from scientists and healthcare professionals is notably high for publications on 5α-reductase inhibitors. The study concludes that healthcare professionals are more selective in their reading compared to the general public, who may struggle to find reliable dermatology sources. Altmetrics effectively quantify readership trends and public interest in dermatology research.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 11 months ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community DHT/Testosterone levels in scalp Fin VS Dut.

      in Finasteride/Dutasteride  60 upvotes 4 months ago
      Dutasteride raises scalp testosterone by 99%, which may not be ideal for those sensitive to all androgens. Some argue finasteride's balancing act might be better, while others believe dutasteride is superior for hair regrowth.

      community 1 month of using fin, so happy

      in Progress Pictures  864 upvotes 3 months ago
      User had a hair transplant and used a finasteride and minoxidil spray for 6 months with no results. After adding finasteride tablets for 1 month, they saw significant hair growth improvement.

    Similar Research

    5 / 1000+ results